We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:URGN
​
​
logo

UroGen Pharma Ltd. (URGN)

Nasdaq • URGN • IL0011407140

28.74Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 12.2% of free float is sold short, 4.4 days to cover, cost to borrow 0.43%.

Market Cap

1.4b USD | # 4206 in US

Volume

1m shares | 41.59m USD

Shares Outstanding

48.88m

Free Float Shares

88.80% | 43.41m

DB:UR8|
LSE:0XOD

News

URGN key data

UroGen Pharma Ltd. (Nasdaq: URGN) has a market capitalization of $1.4B. Last close $28.74 (as of 2026-11-05); 52-week range $16.50 to $50.81. ORTEX data as of 2026-11-03: short interest is 12.17% of free float, 4.4 days to cover and the average cost to borrow is 0.43%.

  • URGN news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.